BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 1 calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:3fb60a0f-e98b-4470-bd68-44b8536aaffb
DTSTAMP:20250617T153036
DTSTART:20250922T100000
DTEND:20250922T110000
SUMMARY:Comms Y1 meet the team
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:26445f8c-df87-478e-9253-c15b09056ae1
DTSTAMP:20250617T153036
DTSTART:20250922T110000
DTEND:20250922T120000
SUMMARY:Comms Y1 meet the team
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:90ce8c06-b0a0-4bef-9e9f-610ad742ec11
DTSTAMP:20250617T153036
DTSTART:20250925T100000
DTEND:20250925T110000
SUMMARY:Labcoat collection (9-10)
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:c31b9ff3-7464-4522-ada5-4ba4bb916a05
DTSTAMP:20250617T153036
DTSTART:20250926T100000
DTEND:20250926T110000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:682047ed-24a4-4499-a7fe-2b01dab1e3c7
DTSTAMP:20250617T153036
DTSTART:20250926T110000
DTEND:20250926T120000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:f9e679fe-d02c-4ed1-84dc-b028d41f506d
DTSTAMP:20250617T153036
DTSTART:20250926T120000
DTEND:20250926T130000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:1d44179a-ac33-4a90-8c47-8baac985bea7
DTSTAMP:20250617T153036
DTSTART:20250926T140000
DTEND:20250926T150000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:abbc3589-180b-4673-bdf8-c08152868cb8
DTSTAMP:20250617T153036
DTSTART:20250926T150000
DTEND:20250926T160000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:0a7e4730-baa1-469d-9fe5-56ba43420651
DTSTAMP:20250617T153036
DTSTART:20250929T110000
DTEND:20250929T120000
SUMMARY:Skills Introduction to module
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:56d00126-ba14-4f75-9ec1-e3a592fc5c8f
DTSTAMP:20250617T153036
DTSTART:20250929T120000
DTEND:20250929T130000
SUMMARY:Introduction to FS and pharmacodynamics
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:d8dadd2d-c1f7-4fc9-b31c-aaa117b1a1ac
DTSTAMP:20250617T153036
DTSTART:20250929T140000
DTEND:20250929T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0a5fdc4d-5a5f-45b6-b5d7-1d3c44da1586
DTSTAMP:20250617T153036
DTSTART:20250929T150000
DTEND:20250929T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:6a5edb6b-f201-4cee-bc21-6d8031320d56
DTSTAMP:20250617T153036
DTSTART:20250930T100000
DTEND:20250930T110000
SUMMARY:FS 1.1 The Body: Introduction
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:cc8f7e2b-fd2b-4fc1-8cab-035a9a55e178
DTSTAMP:20250617T153036
DTSTART:20250930T110000
DTEND:20250930T120000
SUMMARY:FS 1.2 The Body: Tissues
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:c52f929a-3fcb-419f-947e-57b92957f854
DTSTAMP:20250617T153036
DTSTART:20250930T120000
DTEND:20250930T130000
SUMMARY:FS 1.3 The Body: Cells and Molecules
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:1803f9bc-e17c-4985-a5ec-8a131c6c4223
DTSTAMP:20250617T153036
DTSTART:20250930T140000
DTEND:20250930T150000
SUMMARY:Skills 1.1 Numeracy
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b543757f-1d4f-464f-9012-58f078145aa3
DTSTAMP:20250617T153036
DTSTART:20250930T150000
DTEND:20250930T160000
SUMMARY:Skills 1.1 Numeracy
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2b4056e6-3a21-4bbc-9397-af1457f6cab1
DTSTAMP:20250617T153036
DTSTART:20251002T110000
DTEND:20251002T120000
SUMMARY:PD 1.1 Fundamentals - Part I
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:77d750a1-682e-4187-8230-b21ea769f3e6
DTSTAMP:20250617T153036
DTSTART:20251002T120000
DTEND:20251002T130000
SUMMARY:PD 1.2 Fundamentals - Part I
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:2ac6fcc8-d190-40e9-a51b-69539438cb67
DTSTAMP:20250617T153036
DTSTART:20251002T140000
DTEND:20251002T150000
SUMMARY:DS 1.1 Introduction to data and statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:cffc0f68-6214-4ec2-b113-c80af2f9b1d3
DTSTAMP:20250617T153036
DTSTART:20251002T150000
DTEND:20251002T160000
SUMMARY:DS Introduction to excel 3-4.30
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:3d64e269-864e-462e-b8ba-3331cdd5ecaa
DTSTAMP:20250617T153036
DTSTART:20251002T160000
DTEND:20251002T170000
SUMMARY:DS Introduction to excel 3-4.30
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:13e1a235-671d-48d4-8268-058eeb67e4c4
DTSTAMP:20250617T153036
DTSTART:20251003T140000
DTEND:20251003T150000
SUMMARY:DH 1.1 Introduction to drugs in healthcare
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:6673f937-cd40-49ee-b86f-c727f728f2c9
DTSTAMP:20250617T153036
DTSTART:20251003T150000
DTEND:20251003T160000
SUMMARY:DH 1.1 Introduction to drugs in healthcare
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:c1840124-097f-47ca-944c-55478df2dec5
DTSTAMP:20250617T153036
DTSTART:20251006T100000
DTEND:20251006T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ab6fb82a-93fd-41f3-a58d-7f8440d4086e
DTSTAMP:20250617T153036
DTSTART:20251006T110000
DTEND:20251006T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2285a4cc-bd2d-4b3b-8425-3e8b61aad6f2
DTSTAMP:20250617T153036
DTSTART:20251006T120000
DTEND:20251006T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7c3141ee-2c59-4615-953d-6ff4d76798b1
DTSTAMP:20250617T153036
DTSTART:20251006T140000
DTEND:20251006T150000
SUMMARY:Skills 1.2  Introduction to basic lab skills
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:c743995a-9ef9-438f-83ba-532dc91c2ba2
DTSTAMP:20250617T153036
DTSTART:20251006T150000
DTEND:20251006T160000
SUMMARY:Skills 1.2  Introduction to basic lab skills
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dd05ab5e-cf2e-4ffe-b8ac-899300146b4a
DTSTAMP:20250617T153036
DTSTART:20251006T160000
DTEND:20251006T170000
SUMMARY:Skills 1.2  Introduction to basic lab skills
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b0c289a6-1820-442d-93da-bf750f5bdfae
DTSTAMP:20250617T153036
DTSTART:20251007T110000
DTEND:20251007T120000
SUMMARY:FS 1.4 The Body: Control and Regulation
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:5bc52d94-1a5f-4ab8-8325-e19cd2a27553
DTSTAMP:20250617T153036
DTSTART:20251007T120000
DTEND:20251007T130000
SUMMARY:FS 1.5 The Body: Environment and Exchange
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:2252a573-9169-4970-8c19-5ea8a1fc1bbc
DTSTAMP:20250617T153036
DTSTART:20251007T140000
DTEND:20251007T150000
SUMMARY:FS 1.6 The Body: Growth and Energy
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:180c18ee-3110-41ba-aaf4-67b9074cc02c
DTSTAMP:20250617T153036
DTSTART:20251009T110000
DTEND:20251009T120000
SUMMARY:PD 1.3 Fundamentals: Part II
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:abbb0695-70f5-4d97-ab32-5f5d13bdb8c8
DTSTAMP:20250617T153036
DTSTART:20251009T120000
DTEND:20251009T130000
SUMMARY:PD 1.4 Fundamentals: Part II
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:1a7cb502-0d88-4252-9204-0a52917658db
DTSTAMP:20250617T153036
DTSTART:20251009T140000
DTEND:20251009T150000
SUMMARY:DS 1.2 Types of data and how to describe them
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:646527fb-e973-4173-960e-11f8859f70c9
DTSTAMP:20250617T153036
DTSTART:20251009T150000
DTEND:20251009T160000
SUMMARY:DS Excel skills 2
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:e870a69c-4edb-44b4-9934-08dfb0b1b29d
DTSTAMP:20250617T153036
DTSTART:20251009T160000
DTEND:20251009T170000
SUMMARY:DS Excel skills 2
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:7af5b302-5fff-4d3a-b2c0-e42eb785697d
DTSTAMP:20250617T153036
DTSTART:20251010T100000
DTEND:20251010T110000
SUMMARY:DD Introduction to drug development
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:54e7ff3b-2329-40fa-abee-782c2ac74ac8
DTSTAMP:20250617T153036
DTSTART:20251010T110000
DTEND:20251010T120000
SUMMARY:DD Introduction to biomedical research and bias
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:29474230-f5aa-43f4-816d-3b07ffbf305e
DTSTAMP:20250617T153036
DTSTART:20251010T120000
DTEND:20251010T130000
SUMMARY:Comms Introduction to the library
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:29f04773-df1c-42b6-8ef0-6765030bd234
DTSTAMP:20250617T153036
DTSTART:20251010T140000
DTEND:20251010T150000
SUMMARY:PK Introduction to pharmacokinetics
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:b4fa0b07-15d6-4e1c-8918-578ac10974a9
DTSTAMP:20250617T153036
DTSTART:20251010T150000
DTEND:20251010T160000
SUMMARY:Skills WINDEC and hand hygiene [briefing]
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2d584371-68f7-4ea9-a305-8d98af14a358
DTSTAMP:20250617T153036
DTSTART:20251013T100000
DTEND:20251013T110000
SUMMARY:Skills WINDEC and hand hygiene
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:00e6422c-dde0-4fb8-81f2-9e1bef2874ed
DTSTAMP:20250617T153036
DTSTART:20251013T110000
DTEND:20251013T120000
SUMMARY:Skills WINDEC and hand hygiene
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:eaa2df3e-e34d-4ef1-8e2c-858eb3861a07
DTSTAMP:20250617T153036
DTSTART:20251013T120000
DTEND:20251013T130000
SUMMARY:Skills WINDEC and hand hygiene
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:16f93243-0afb-4793-81d4-55ced1d861d3
DTSTAMP:20250617T153036
DTSTART:20251013T140000
DTEND:20251013T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:85a1d590-1400-4caa-a4e2-775fe09cb7a6
DTSTAMP:20250617T153036
DTSTART:20251013T150000
DTEND:20251013T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a4b0cf1a-92d9-4bac-a400-fb73697f4726
DTSTAMP:20250617T153036
DTSTART:20251014T100000
DTEND:20251014T110000
SUMMARY:FS 1.7 Chemical Mediators
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:1c9d7560-c8af-4814-9da9-a5068a011ecf
DTSTAMP:20250617T153036
DTSTART:20251014T110000
DTEND:20251014T120000
SUMMARY:FS 1.8 Cell division and fate
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:7367cbdd-6561-4580-9830-1b7989872dad
DTSTAMP:20250617T153036
DTSTART:20251014T120000
DTEND:20251014T130000
SUMMARY:FS 1.9 DNA to Gene Expression
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:2a046b05-cbd0-4b50-ad81-9ad923f9ac65
DTSTAMP:20250617T153036
DTSTART:20251015T100000
DTEND:20251015T110000
SUMMARY:WEC Pharmacy visits - Group 1 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4493e21d-8625-4048-8f29-2ca44946dbf2
DTSTAMP:20250617T153036
DTSTART:20251015T110000
DTEND:20251015T120000
SUMMARY:WEC Pharmacy visits - Group 1 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:63aee036-5e3a-4267-8d82-a21745a54ccb
DTSTAMP:20250617T153036
DTSTART:20251016T100000
DTEND:20251016T110000
SUMMARY:PK 1.1 Drug formulation
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:490e4d21-44ce-4a65-aa6f-277e1789df9b
DTSTAMP:20250617T153036
DTSTART:20251016T110000
DTEND:20251016T120000
SUMMARY:WEC Introduction to careers
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:301c1f90-caaf-4fe5-ac44-5c0e826e9fc4
DTSTAMP:20250617T153036
DTSTART:20251016T120000
DTEND:20251016T130000
SUMMARY:WEC Introduction to careers
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:6b994f65-a30d-47ae-ac11-943f390c6906
DTSTAMP:20250617T153036
DTSTART:20251016T140000
DTEND:20251016T150000
SUMMARY:PD 1.5 Fundamentals -Part 3
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:40fdad1a-0029-48a7-a72a-5710fc80f075
DTSTAMP:20250617T153036
DTSTART:20251016T150000
DTEND:20251016T160000
SUMMARY:PD 1.6 Fundamentals -Part 3
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:6b57d795-930a-4493-b403-1fb975bdc397
DTSTAMP:20250617T153036
DTSTART:20251017T110000
DTEND:20251017T120000
SUMMARY:FS recap Key Concepts
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:67c11da1-aa0e-4355-83eb-30249ae744c3
DTSTAMP:20250617T153036
DTSTART:20251017T120000
DTEND:20251017T130000
SUMMARY:FS recap Key Concepts
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:00bce384-b81c-4f32-ba39-022a8c2ffa49
DTSTAMP:20250617T153036
DTSTART:20251017T140000
DTEND:20251017T150000
SUMMARY:DH 1.2  How do healthcare professionals decide which medicines a patient needs?
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:39f077c8-a794-4007-9e96-352d495ac4ca
DTSTAMP:20250617T153036
DTSTART:20251017T150000
DTEND:20251017T160000
SUMMARY:DH 1.2  How do healthcare professionals decide which medicines a patient needs?
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:c54a1b57-472f-4125-b085-594ec41706f8
DTSTAMP:20250617T153036
DTSTART:20251020T100000
DTEND:20251020T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3377549e-4b23-413b-8875-284b3bf64cdf
DTSTAMP:20250617T153036
DTSTART:20251020T110000
DTEND:20251020T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:1210bd7d-beef-4893-bd1c-e439a60194ae
DTSTAMP:20250617T153036
DTSTART:20251020T120000
DTEND:20251020T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:efde46f7-0042-4e25-a6dc-2cfae715cd81
DTSTAMP:20250617T153036
DTSTART:20251020T140000
DTEND:20251020T150000
SUMMARY:Skills 1.3  Spectrophotometry 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e96d79ca-129f-4dcf-ace4-7021bd493e86
DTSTAMP:20250617T153036
DTSTART:20251020T150000
DTEND:20251020T160000
SUMMARY:Skills 1.3  Spectrophotometry 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:00e31cf6-115f-402a-8256-308302e200a7
DTSTAMP:20250617T153036
DTSTART:20251020T160000
DTEND:20251020T170000
SUMMARY:Skills 1.3  Spectrophotometry 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8f6a076f-31e1-449e-b2c0-41f4eaf8d5c9
DTSTAMP:20250617T153036
DTSTART:20251021T110000
DTEND:20251021T120000
SUMMARY:DD Target selection and validation
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:a12621a2-ce76-4265-a29f-e0182efffeac
DTSTAMP:20250617T153036
DTSTART:20251021T120000
DTEND:20251021T130000
SUMMARY:DD  Lead generation and optimisation
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:f68f09ee-91dd-4d37-a83e-fc76c4aa0296
DTSTAMP:20250617T153036
DTSTART:20251021T140000
DTEND:20251021T150000
SUMMARY:FS 1.10 G protein coupled receptors
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:f20541fe-8f04-4d0b-9f56-26f5911fb2fc
DTSTAMP:20250617T153036
DTSTART:20251021T150000
DTEND:20251021T160000
SUMMARY:FS 1.11 Membrane Potentials and Action Potentials
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:c412e202-a411-4952-b85b-b2f98ee52915
DTSTAMP:20250617T153036
DTSTART:20251023T100000
DTEND:20251023T110000
SUMMARY:Skills Routes of administration [briefing]
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9c36b333-10b5-4f76-b4b2-e3256433ae7f
DTSTAMP:20250617T153036
DTSTART:20251023T110000
DTEND:20251023T120000
SUMMARY:FS 1.12 Autonomic nervous system 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:ec316814-82df-4370-8a7b-e32912083ffa
DTSTAMP:20250617T153036
DTSTART:20251023T120000
DTEND:20251023T130000
SUMMARY:FS 1.13 Autonomic nervous system 2
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:b9ccd783-f992-4291-91cf-c17f8a015bee
DTSTAMP:20250617T153036
DTSTART:20251023T140000
DTEND:20251023T150000
SUMMARY:DS 1.3  Introduction to clinical study design
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:62a83967-0073-43a5-84c7-158646d55b89
DTSTAMP:20250617T153036
DTSTART:20251023T150000
DTEND:20251023T160000
SUMMARY:DS Spreadsheet design
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:7847b328-518e-4f76-b0b7-c3e548bc0bac
DTSTAMP:20250617T153036
DTSTART:20251023T160000
DTEND:20251023T170000
SUMMARY:DS Spreadsheet design
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:a03c28ac-ecbe-457b-923f-0f8a8e84984c
DTSTAMP:20250617T153036
DTSTART:20251024T110000
DTEND:20251024T120000
SUMMARY:PK 1.2 Enteral administration
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:eed63afd-703d-4014-9e74-3aaca52dcbe3
DTSTAMP:20250617T153036
DTSTART:20251024T120000
DTEND:20251024T130000
SUMMARY:PK 1.3 Parenteral administration
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:168bf47c-1116-4d1e-81fc-c4cdcf9b4c07
DTSTAMP:20250617T153036
DTSTART:20251024T130000
DTEND:20251024T140000
SUMMARY:WEC Lunch and learn
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:aa60ec06-4728-466b-b9ee-b3527071970d
DTSTAMP:20250617T153036
DTSTART:20251024T140000
DTEND:20251024T150000
SUMMARY:PD 1.7 Drugs targeting ANS -Part 1:  Sympathetic/Parasympathetic GPCRs
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:5f0a0838-6c5e-4959-b80d-5cf6343cec81
DTSTAMP:20250617T153036
DTSTART:20251024T150000
DTEND:20251024T160000
SUMMARY:DH 1.4  How drugs are used in hospitals
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:464e8e60-1d01-4e87-bc25-be3cb55cf322
DTSTAMP:20250617T153036
DTSTART:20251027T100000
DTEND:20251027T110000
SUMMARY:Skills Routes of administration
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b0f0a1f8-5fe8-4713-9783-bd22e1eb0f34
DTSTAMP:20250617T153036
DTSTART:20251027T110000
DTEND:20251027T120000
SUMMARY:Skills Routes of administration
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7c0e82f7-a6f3-4748-9d29-9fb9d7b2c120
DTSTAMP:20250617T153036
DTSTART:20251027T120000
DTEND:20251027T130000
SUMMARY:Skills Routes of administration
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:30dc7c50-f307-4847-b86a-19c0c8738099
DTSTAMP:20250617T153036
DTSTART:20251027T140000
DTEND:20251027T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f8f0122b-b7d6-4cb7-b80b-3cd0814b02df
DTSTAMP:20250617T153036
DTSTART:20251027T150000
DTEND:20251027T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:bf00a8a4-25b3-4547-bd2e-afbe925e9e9c
DTSTAMP:20250617T153036
DTSTART:20251028T110000
DTEND:20251028T120000
SUMMARY:FS 1.16 Excitable Cells
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:1d5d8bb8-ff13-4625-8afa-8b9942bb2608
DTSTAMP:20250617T153036
DTSTART:20251030T110000
DTEND:20251030T120000
SUMMARY:FS 1.14 Ion Channels
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:56bc6004-86ed-4dd0-94e8-2ea2a3d92e16
DTSTAMP:20250617T153036
DTSTART:20251030T120000
DTEND:20251030T130000
SUMMARY:FS 1.15  LGICRs
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:d9df1d23-15b5-4f8c-921a-80c7aaedb296
DTSTAMP:20250617T153036
DTSTART:20251030T140000
DTEND:20251030T150000
SUMMARY:PD 1.8 Drugs targenting ANS Part II - ANS scenarios
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:40b19343-6023-44f1-8292-2e12f57b266c
DTSTAMP:20250617T153036
DTSTART:20251030T150000
DTEND:20251030T160000
SUMMARY:PK 1.4 Drug absorption
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:1c94d2f6-bb58-49bc-bd85-2c88086a6ed6
DTSTAMP:20250617T153036
DTSTART:20251031T100000
DTEND:20251031T110000
SUMMARY:Presentation skills course groups 1&2 
NB. 10-1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:fc3e2b6e-21d8-44c5-b949-603148b8c62e
DTSTAMP:20250617T153036
DTSTART:20251031T110000
DTEND:20251031T120000
SUMMARY:DH Taking a drug history groups 3&4. 
NB 10-1
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:2edaf0b7-226d-4cfb-a8ce-4d1b6558584d
DTSTAMP:20250617T153036
DTSTART:20251031T140000
DTEND:20251031T150000
SUMMARY:Team based learning 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9125df96-2064-4c11-b789-81cd81a37185
DTSTAMP:20250617T153036
DTSTART:20251031T150000
DTEND:20251031T160000
SUMMARY:Team based learning 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b7070c97-4eec-4051-8ea0-8aa811c7faf7
DTSTAMP:20250617T153036
DTSTART:20251103T100000
DTEND:20251103T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:26429d99-009c-486e-b51f-591be49b884f
DTSTAMP:20250617T153036
DTSTART:20251103T110000
DTEND:20251103T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7547008b-3fb2-4bdd-86ff-4c841762012f
DTSTAMP:20250617T153036
DTSTART:20251103T120000
DTEND:20251103T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b564c310-89fa-4b9d-bbf3-d2360a8eb288
DTSTAMP:20250617T153036
DTSTART:20251103T140000
DTEND:20251103T150000
SUMMARY:Skills 1.4 DNA practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:240e7ec6-5f32-46ce-a128-0f7c00878349
DTSTAMP:20250617T153036
DTSTART:20251103T150000
DTEND:20251103T160000
SUMMARY:Skills 1.4 DNA practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:1c092d6b-83e2-4960-bd2e-b2cd6cedb37f
DTSTAMP:20250617T153036
DTSTART:20251103T160000
DTEND:20251103T170000
SUMMARY:Skills 1.4 DNA practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4f267b40-754f-4393-99d2-a8cfa1764cc7
DTSTAMP:20250617T153036
DTSTART:20251104T110000
DTEND:20251104T120000
SUMMARY:FS 1.17 Skeletal muscle contraction and NMJ
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:f73e0a5e-58ad-4bc4-9079-dc96e31deaf7
DTSTAMP:20250617T153036
DTSTART:20251104T120000
DTEND:20251104T130000
SUMMARY:FS 1.18 Smooth muscle contraction
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:cf0445d8-f5f4-4b01-95f0-ac32c044ceaf
DTSTAMP:20250617T153036
DTSTART:20251104T140000
DTEND:20251104T150000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:b158f29c-16cd-4ca2-b063-c6495cb4f258
DTSTAMP:20250617T153036
DTSTART:20251104T150000
DTEND:20251104T160000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:41df006f-c076-49e0-9c01-fbd73cecd203
DTSTAMP:20250617T153036
DTSTART:20251105T100000
DTEND:20251105T110000
SUMMARY:WEC Pharmacy visits - Group 2 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3083f618-f7a4-4587-b299-f2a69bc96fb5
DTSTAMP:20250617T153036
DTSTART:20251105T110000
DTEND:20251105T120000
SUMMARY:WEC Pharmacy visits - Group 2 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3a3117df-c3fe-44ef-b81f-13ae7710dcdf
DTSTAMP:20250617T153036
DTSTART:20251106T110000
DTEND:20251106T120000
SUMMARY:FS recap Control and Regulation 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:8e710219-5432-4706-a6b0-7f4d3bc4a17f
DTSTAMP:20250617T153036
DTSTART:20251106T120000
DTEND:20251106T130000
SUMMARY:FS recap Control and Regulation 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:08112f8d-9a0d-480c-98f3-cfd076e45437
DTSTAMP:20250617T153036
DTSTART:20251106T140000
DTEND:20251106T150000
SUMMARY:DS 1.4 Hypothesis testing
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:d0005ad8-67c6-4175-bb29-0be08ad7e384
DTSTAMP:20250617T153036
DTSTART:20251106T150000
DTEND:20251106T160000
SUMMARY:DS Introduction to SPSS
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:8226660e-fa37-4a65-b316-49e539420e3e
DTSTAMP:20250617T153036
DTSTART:20251106T160000
DTEND:20251106T170000
SUMMARY:DS Introduction to SPSS
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:4ee1a3d9-c805-4f97-a392-9b6852870217
DTSTAMP:20250617T153036
DTSTART:20251107T100000
DTEND:20251107T110000
SUMMARY:Presentation skills course groups 1&2 
NB. 10-1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:31beba59-4ce5-46ba-a331-1a60249c78e9
DTSTAMP:20250617T153036
DTSTART:20251107T110000
DTEND:20251107T120000
SUMMARY:DH Taking a drug history groups 3&4. 
NB 10-1
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:ad1feb9f-04ae-44ec-ade6-2d53b6bf7c82
DTSTAMP:20250617T153036
DTSTART:20251107T140000
DTEND:20251107T150000
SUMMARY:DD Introduction to clinical trials
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:5830e6ac-5dd4-4fd1-953d-5c8cac7246f4
DTSTAMP:20250617T153036
DTSTART:20251107T150000
DTEND:20251107T160000
SUMMARY:DD Drug discovery in rare diseases
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:3ce62884-9562-4e2e-82a1-d5d1af6ed3f4
DTSTAMP:20250617T153036
DTSTART:20251107T160000
DTEND:20251107T170000
SUMMARY:DD Drug discovery in rare diseases
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:02c0bbf7-66ae-4691-a734-aa1ce3fceab8
DTSTAMP:20250617T153036
DTSTART:20251110T100000
DTEND:20251110T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b79b83ec-5e95-485b-baf6-427205c128b7
DTSTAMP:20250617T153036
DTSTART:20251110T110000
DTEND:20251110T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8581dc1d-120b-42a0-8f02-00b253560907
DTSTAMP:20250617T153036
DTSTART:20251110T120000
DTEND:20251110T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9c167b5f-db3a-4676-b45c-8a9994d4456d
DTSTAMP:20250617T153036
DTSTART:20251110T140000
DTEND:20251110T150000
SUMMARY:Skills 1.5 Volume of distribution
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:6cb4b16f-a9c7-48ea-a414-d6b0881a951a
DTSTAMP:20250617T153036
DTSTART:20251110T150000
DTEND:20251110T160000
SUMMARY:Skills 1.5 Volume of distribution
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d0180115-0393-4d53-8d34-cec89734b96a
DTSTAMP:20250617T153036
DTSTART:20251111T120000
DTEND:20251111T130000
SUMMARY:Skills Measuring vital signs [briefing]
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:79a0823c-255a-4bd7-adba-3d0d17712ff0
DTSTAMP:20250617T153036
DTSTART:20251111T130000
DTEND:20251111T140000
SUMMARY:PK 1.8 Volume of distribution
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:c38f28ca-4204-4d74-9f5d-670e2056501e
DTSTAMP:20250617T153036
DTSTART:20251111T140000
DTEND:20251111T150000
SUMMARY:PK Volume of distribution - introduction to calculations
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:266f5123-74b1-4ba0-b06d-99d1780e0d2f
DTSTAMP:20250617T153036
DTSTART:20251112T100000
DTEND:20251112T110000
SUMMARY:WEC Pharmacy visits - Group 3 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:acdba015-24e3-4bab-a7e1-53da856c0ba8
DTSTAMP:20250617T153036
DTSTART:20251112T110000
DTEND:20251112T120000
SUMMARY:WEC Pharmacy visits - Group 3 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:038bb47b-0a30-4e6a-838d-eb1ab606e0ef
DTSTAMP:20250617T153036
DTSTART:20251113T100000
DTEND:20251113T110000
SUMMARY:Comms Course director/year lead check in 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5b093913-e435-4c0f-9fc8-7ca6b0975529
DTSTAMP:20250617T153036
DTSTART:20251113T110000
DTEND:20251113T120000
SUMMARY:FS 1.19 Body compartments and biological barriers 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:1cad55f0-5d07-459c-bd0c-c0d9a5a051bf
DTSTAMP:20250617T153036
DTSTART:20251113T120000
DTEND:20251113T130000
SUMMARY:FS 1.20 Body compartments and biological barriers 2
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:61e3afec-f5ed-40e0-9fb4-e6aa9a36f24c
DTSTAMP:20250617T153036
DTSTART:20251113T140000
DTEND:20251113T150000
SUMMARY:DS 1.5 Descriptive vs inferential statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:03fa88b6-8eae-4903-87e8-70233253450f
DTSTAMP:20250617T153036
DTSTART:20251113T150000
DTEND:20251113T160000
SUMMARY:DS Descriptive vs inferential statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:7a0958b2-47f4-441b-bcd9-7b6519409798
DTSTAMP:20250617T153036
DTSTART:20251113T160000
DTEND:20251113T170000
SUMMARY:DS  Descriptive vs inferential statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:bff14dc3-9b3e-40f0-b567-21716d81fedf
DTSTAMP:20250617T153036
DTSTART:20251114T100000
DTEND:20251114T110000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:f45fd328-057c-46ca-aadd-c93a6237037e
DTSTAMP:20250617T153036
DTSTART:20251114T110000
DTEND:20251114T120000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:0b0cfc60-ab0a-4f3d-a91e-cbb7b27729b1
DTSTAMP:20250617T153036
DTSTART:20251114T120000
DTEND:20251114T130000
SUMMARY:Comms Wellbeing - looking after ourselves
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4349e459-789e-4032-b944-3cfc178d26be
DTSTAMP:20250617T153036
DTSTART:20251114T140000
DTEND:20251114T150000
SUMMARY:PD Recap workshop
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:602ff6d6-b5ed-4053-9472-f5b6dc7af625
DTSTAMP:20250617T153036
DTSTART:20251114T150000
DTEND:20251114T160000
SUMMARY:PD Recap workshop
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:713579ba-a80c-4895-8be7-97a4eb647def
DTSTAMP:20250617T153036
DTSTART:20251117T100000
DTEND:20251117T110000
SUMMARY:Skills Measuring vital signs
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8f41afbd-ff79-4e83-86ad-cdc91c32c003
DTSTAMP:20250617T153036
DTSTART:20251117T110000
DTEND:20251117T120000
SUMMARY:Skills Measuring vital signs
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:56c6066e-0046-4b6b-ad05-fa7fb74d4d75
DTSTAMP:20250617T153036
DTSTART:20251117T120000
DTEND:20251117T130000
SUMMARY:Skills Measuring vital signs
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5351594d-377a-4be5-95b5-674187fb6a07
DTSTAMP:20250617T153036
DTSTART:20251117T140000
DTEND:20251117T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:cc4a315b-5e58-4505-a96a-fcd8e86327f2
DTSTAMP:20250617T153036
DTSTART:20251117T150000
DTEND:20251117T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:20c8f1fa-5d8c-4a1c-8fc5-598dcb0926c0
DTSTAMP:20250617T153036
DTSTART:20251118T140000
DTEND:20251118T150000
SUMMARY:Skills Dissection 1. Liver and kidney
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d9a9f216-28c4-4b11-9c4e-9f16e2b2a309
DTSTAMP:20250617T153036
DTSTART:20251118T150000
DTEND:20251118T160000
SUMMARY:Dissection 1. Liver and kidney
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:925bf128-7800-47dd-97d5-74c943b46036
DTSTAMP:20250617T153036
DTSTART:20251119T100000
DTEND:20251119T110000
SUMMARY:WEC Pharmacy visits - Group 4 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8eb6ffd9-2361-42ec-8869-57e4f22bad33
DTSTAMP:20250617T153036
DTSTART:20251119T110000
DTEND:20251119T120000
SUMMARY:WEC Pharmacy visits - Group 4 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:45be269e-7a98-49d0-a62c-2f041e9c9c3f
DTSTAMP:20250617T153036
DTSTART:20251120T100000
DTEND:20251120T110000
SUMMARY:FS 1.21 Liver structure and function
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:2726faef-dacd-4323-82f8-5ce6580f0ed7
DTSTAMP:20250617T153036
DTSTART:20251120T110000
DTEND:20251120T120000
SUMMARY:FS 1.22 Liver structure and function
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:fda925e0-b751-4bf8-9d58-adf0f574b8c5
DTSTAMP:20250617T153036
DTSTART:20251120T120000
DTEND:20251120T130000
SUMMARY:PK 1.7 Drug metabolism by the liver 1
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:13467062-1895-4502-b756-b11aeafb85d1
DTSTAMP:20250617T153036
DTSTART:20251120T140000
DTEND:20251120T150000
SUMMARY:DS term 1 - pulling it all together
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:74f29547-9c8e-480d-a8f7-5994c0faac3c
DTSTAMP:20250617T153036
DTSTART:20251120T150000
DTEND:20251120T160000
SUMMARY:DS Liver adverse drug reaction analysis
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:db195b56-1046-41bf-9435-31edfc5d29eb
DTSTAMP:20250617T153036
DTSTART:20251120T160000
DTEND:20251120T170000
SUMMARY:DS  Liver adverse drug reaction analysis
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:0ab7738a-f4e4-4787-a338-7962f255a768
DTSTAMP:20250617T153036
DTSTART:20251121T110000
DTEND:20251121T120000
SUMMARY:DD Science techniques
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:e5aadb70-25ba-4ac8-a81b-37b7354b967c
DTSTAMP:20250617T153036
DTSTART:20251121T120000
DTEND:20251121T130000
SUMMARY:DD Science techniques
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:aec96aa0-1a1d-4d3e-9f5f-57378a988f01
DTSTAMP:20250617T153036
DTSTART:20251121T140000
DTEND:20251121T150000
SUMMARY:Team based learning 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:6b3c0b50-bc1e-46bd-b497-32b691b4815b
DTSTAMP:20250617T153036
DTSTART:20251121T150000
DTEND:20251121T160000
SUMMARY:Team based learning 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f62c7440-8f6a-4431-ba15-11ad464d48a1
DTSTAMP:20250617T153036
DTSTART:20251124T100000
DTEND:20251124T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:87cfded1-e7f0-4fc9-9729-b40fd2e67bca
DTSTAMP:20250617T153036
DTSTART:20251124T110000
DTEND:20251124T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:860aa112-a4c0-44c7-ad01-78bf1154a55c
DTSTAMP:20250617T153036
DTSTART:20251124T120000
DTEND:20251124T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ede65c98-7381-4308-a512-1ac340722ae6
DTSTAMP:20250617T153036
DTSTART:20251124T140000
DTEND:20251124T150000
SUMMARY:Skills 1.7  Spectrophotometry 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:35d859e0-3899-4378-9091-b9214202c162
DTSTAMP:20250617T153036
DTSTART:20251124T150000
DTEND:20251124T160000
SUMMARY:Skills 1.7  Spectrophotometry 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7fa7cc28-1308-4ff7-8f43-20f5bb7deb1d
DTSTAMP:20250617T153036
DTSTART:20251124T160000
DTEND:20251124T170000
SUMMARY:Skills 1.7  Spectrophotometry 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2c403ed4-ff69-4e73-ac74-f0a80a75dc4c
DTSTAMP:20250617T153036
DTSTART:20251125T110000
DTEND:20251125T120000
SUMMARY:FS 1.23 Structure and function of the kidney
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:64946894-5830-406f-9dc0-7d90efc4444b
DTSTAMP:20250617T153036
DTSTART:20251125T120000
DTEND:20251125T130000
SUMMARY:FS 1.23 Structure and function of the kidney
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:0c15fdab-5158-49bc-b5fe-de82430ab3df
DTSTAMP:20250617T153036
DTSTART:20251126T100000
DTEND:20251126T110000
SUMMARY:WEC Pharmacy visits - Group 5 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:34f3b2ad-e4bd-4221-8fdf-e2b5891a3c88
DTSTAMP:20250617T153036
DTSTART:20251126T110000
DTEND:20251126T120000
SUMMARY:WEC Pharmacy visits - Group 5 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:fe90bf5c-48a6-424c-bfbc-f21fc656b78a
DTSTAMP:20250617T153036
DTSTART:20251127T110000
DTEND:20251127T120000
SUMMARY:PK 1.9 Drug excretion including renal elimination
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:0c6777b2-c7a6-427c-b31b-cfcc1dad9d28
DTSTAMP:20250617T153036
DTSTART:20251127T120000
DTEND:20251127T130000
SUMMARY:PK 1.10 Drug clearance
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:a55f708e-ca6a-4cce-9c53-48841213ac3e
DTSTAMP:20250617T153036
DTSTART:20251127T140000
DTEND:20251127T150000
SUMMARY:PK Joint workshop with fundamentals of science
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:5b3cadb1-f080-4654-92cd-a3cb864ec2f9
DTSTAMP:20250617T153036
DTSTART:20251127T150000
DTEND:20251127T160000
SUMMARY:FS Joint workshop with pharmacokinetics
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:41ed4c75-460b-4d4a-96a4-fa550d500a63
DTSTAMP:20250617T153036
DTSTART:20251128T110000
DTEND:20251128T120000
SUMMARY:DH 1.5 Therapeutic journey from prescription to outcome
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:e0c815a1-f22d-41a6-bc82-f2cacca1c8b1
DTSTAMP:20250617T153036
DTSTART:20251128T120000
DTEND:20251128T130000
SUMMARY:DH 1.5 Therapeutic journey from prescription to outcome
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:4747a27d-9639-41c2-810f-b6aae6f38b66
DTSTAMP:20250617T153036
DTSTART:20251128T140000
DTEND:20251128T150000
SUMMARY:PK Recap and review
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:3a4d4148-1e1d-49e9-a90f-e3fe219f1de4
DTSTAMP:20250617T153036
DTSTART:20251128T150000
DTEND:20251128T160000
SUMMARY:PK Recap and review
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:cbd3b9de-58fe-4d43-b2a0-c5c0a324812f
DTSTAMP:20250617T153036
DTSTART:20251208T140000
DTEND:20251208T150000
SUMMARY:Assess Big quiz 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:db9bf983-da06-4a90-8051-d2f65bbeb539
DTSTAMP:20250617T153036
DTSTART:20251208T150000
DTEND:20251208T160000
SUMMARY:Assess Big quiz 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f0b0c5c1-bff9-40c4-ae9e-b5f471094c46
DTSTAMP:20250617T153036
DTSTART:20251208T160000
DTEND:20251208T170000
SUMMARY:Christmas social
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:a339486a-618c-43e8-a6a7-a5110604d8a8
DTSTAMP:20250617T153036
DTSTART:20260105T100000
DTEND:20260105T110000
SUMMARY:HUB NB Need computer lab too for Assess BQ1 resits
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dabce3c5-ce4b-4ecb-91e5-2538527bc8dc
DTSTAMP:20250617T153036
DTSTART:20260105T110000
DTEND:20260105T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:156f2753-90fe-4510-b4a0-fea93c58dfe3
DTSTAMP:20250617T153036
DTSTART:20260105T120000
DTEND:20260105T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b71fc57c-a9fc-494b-96d1-0188d3ef295d
DTSTAMP:20250617T153036
DTSTART:20260105T140000
DTEND:20260105T150000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:8f789cc6-d49d-4fec-a761-3bc912e5fa02
DTSTAMP:20250617T153036
DTSTART:20260105T150000
DTEND:20260105T160000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:366aa041-f82d-4125-abaf-33d4d0118b8e
DTSTAMP:20250617T153036
DTSTART:20260106T110000
DTEND:20260106T120000
SUMMARY:FS 1.27 Immunity 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:4ffc6c43-c2da-41c1-a1cc-62d90bb12364
DTSTAMP:20250617T153036
DTSTART:20260106T120000
DTEND:20260106T130000
SUMMARY:FS 1.28 Immunity 2
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:997ced8c-df8b-4890-82d6-304a48cdc1c6
DTSTAMP:20250617T153036
DTSTART:20260108T100000
DTEND:20260108T110000
SUMMARY:Comms Course director/year lead check in 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e18d3fb6-1b9c-4091-bee1-6ad64960eb91
DTSTAMP:20250617T153036
DTSTART:20260108T110000
DTEND:20260108T120000
SUMMARY:FS 1.29 Structure and function of blood
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:bdc20e31-32e0-4bb6-af8e-7d4b21207c42
DTSTAMP:20250617T153036
DTSTART:20260108T120000
DTEND:20260108T130000
SUMMARY:FS 1.30 Blood disorders
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:7ba5da39-0229-44f7-afe2-e3ee90a85a69
DTSTAMP:20250617T153036
DTSTART:20260108T140000
DTEND:20260108T150000
SUMMARY:DS 1.7 Comparing and visualising quantitative data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:744f85d7-5fdc-484f-b768-c5591c5aa587
DTSTAMP:20250617T153036
DTSTART:20260108T150000
DTEND:20260108T160000
SUMMARY:DS 1.7 Comparing and visualising quantitative data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:d1e1eb5a-d6ae-4b3c-a418-c551bdc95825
DTSTAMP:20250617T153036
DTSTART:20260108T160000
DTEND:20260108T170000
SUMMARY:DS 1.7 Comparing and visualising quantitative data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:7c0029ec-e575-4583-aa1c-7e313d8599f2
DTSTAMP:20250617T153036
DTSTART:20260109T100000
DTEND:20260109T110000
SUMMARY:DD Designing a clinical study
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:9f6f1b7e-e663-478f-96c1-5a82dd236083
DTSTAMP:20250617T153036
DTSTART:20260109T110000
DTEND:20260109T120000
SUMMARY:DD Designing a clinical study
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:96d18656-4fe1-47ba-8177-53bfa17164ef
DTSTAMP:20250617T153036
DTSTART:20260109T120000
DTEND:20260109T130000
SUMMARY:DD Briefing on handling biological samples (urine) for aspirin practical
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:cc2c33d2-b5ff-4b81-997b-91df32ab4bff
DTSTAMP:20250617T153036
DTSTART:20260109T140000
DTEND:20260109T150000
SUMMARY:PD 2.13 Anti-platelet and fibrinolytic agents
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:d7d66225-4705-4148-8ff7-f6580a632ee4
DTSTAMP:20250617T153036
DTSTART:20260109T150000
DTEND:20260109T160000
SUMMARY:DH 2.9 Platelets as drug targets - arterial thrombosis
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:473c96fb-f88a-46b9-a3aa-357796c3e997
DTSTAMP:20250617T153036
DTSTART:20260112T100000
DTEND:20260112T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ff8e469e-f6e0-46f3-a09d-187598862b59
DTSTAMP:20250617T153036
DTSTART:20260112T110000
DTEND:20260112T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dbf419bc-cc2e-460e-b34c-8a70b46d30e3
DTSTAMP:20250617T153036
DTSTART:20260112T120000
DTEND:20260112T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d5d9b17e-2f38-4559-9c90-9dba7d95c67b
DTSTAMP:20250617T153036
DTSTART:20260112T140000
DTEND:20260112T150000
SUMMARY:Skills 1.11  Spectrophotometry 3. 
Aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:16bd530c-dc20-40d3-bd61-f41a81df6878
DTSTAMP:20250617T153036
DTSTART:20260112T150000
DTEND:20260112T160000
SUMMARY:Skills 1.11  Spectrophotometry 3. 
Aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f383c796-22b3-4333-8ccf-81c85ace42b8
DTSTAMP:20250617T153036
DTSTART:20260112T160000
DTEND:20260112T170000
SUMMARY:Skills 1.11  Spectrophotometry 3. 
Aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:672685a1-3da4-47df-91f3-def78d834fe5
DTSTAMP:20250617T153036
DTSTART:20260113T120000
DTEND:20260113T130000
SUMMARY:Skills Writing up the aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9949c2a4-8499-4085-9387-aa5c789e858f
DTSTAMP:20250617T153036
DTSTART:20260113T140000
DTEND:20260113T150000
SUMMARY:FS 2.14  Blood Coagulation
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:8e76958a-a1c1-43f6-b1cb-bc8236703a50
DTSTAMP:20250617T153036
DTSTART:20260113T150000
DTEND:20260113T160000
SUMMARY:FS 2.15 Blood Coagulation
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:eac2a5ed-bab5-4bf4-abcc-2bf205b76f06
DTSTAMP:20250617T153036
DTSTART:20260115T100000
DTEND:20260115T110000
SUMMARY:Comms - introduction to literature searching
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f16e78df-dc0a-4c94-9453-89a10abcdf82
DTSTAMP:20250617T153036
DTSTART:20260115T110000
DTEND:20260115T120000
SUMMARY:PD 2.14  Anticoagulants
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:9259959a-a474-4d54-bf20-3b1a4e2fed87
DTSTAMP:20250617T153036
DTSTART:20260115T120000
DTEND:20260115T130000
SUMMARY:PD 2.15 Anticoagulants
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:c6c8cbad-059e-4287-a9b1-e7b2d73614ef
DTSTAMP:20250617T153036
DTSTART:20260115T140000
DTEND:20260115T150000
SUMMARY:DH 1.6 How is the NHS structured?
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:f001bd30-8317-4f7e-9957-4bb612c9a7ad
DTSTAMP:20250617T153036
DTSTART:20260115T150000
DTEND:20260115T160000
SUMMARY:PK 1.12 Therapeutic drug monitoring
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:3f8acc53-05d4-4a86-8649-208b44352507
DTSTAMP:20250617T153036
DTSTART:20260116T100000
DTEND:20260116T110000
SUMMARY:DS 1.8 Comparing and visualising categorical data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:f894ae7a-9a07-48ae-8ad9-36da637b175f
DTSTAMP:20250617T153036
DTSTART:20260116T110000
DTEND:20260116T120000
SUMMARY:DS 1.8 Comparing and visualising categorical data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:bb140e4a-4b2d-4380-9ae7-939d29d841fb
DTSTAMP:20250617T153036
DTSTART:20260116T120000
DTEND:20260116T130000
SUMMARY:DS  Aspirin practical analysis
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:a9933ffd-98fd-45a8-835e-d0eca6b00be8
DTSTAMP:20250617T153036
DTSTART:20260116T140000
DTEND:20260116T150000
SUMMARY:DBL Karen Jones
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:fc12ae3a-2b16-4c3f-82a7-89cd39486801
DTSTAMP:20250617T153036
DTSTART:20260116T150000
DTEND:20260116T160000
SUMMARY:DBL Karen Jones
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:1424971d-fe68-454b-b0ca-eeffd8c39bac
DTSTAMP:20250617T153036
DTSTART:20260119T100000
DTEND:20260119T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5f12630c-305a-4550-ab99-5cbb417a28a5
DTSTAMP:20250617T153036
DTSTART:20260119T110000
DTEND:20260119T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e11469e1-f2db-4dca-a65e-4560adfcf7d3
DTSTAMP:20250617T153036
DTSTART:20260119T120000
DTEND:20260119T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4924488b-2599-4bc6-b693-26e5feb32cd9
DTSTAMP:20250617T153036
DTSTART:20260119T140000
DTEND:20260119T150000
SUMMARY:Dragon's den poster drop in
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0ee4c491-5a81-4d9e-aecd-ec6a03c0142b
DTSTAMP:20250617T153036
DTSTART:20260119T150000
DTEND:20260119T160000
SUMMARY:Dragon's den poster drop in
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:314a85fe-27b4-4dc3-80b2-04e2fa4b4435
DTSTAMP:20250617T153036
DTSTART:20260120T100000
DTEND:20260120T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8de3962a-080c-4637-934b-03185cdcfb0d
DTSTAMP:20250617T153036
DTSTART:20260120T110000
DTEND:20260120T120000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:87415fe1-f1ad-4741-b109-3e587d195c11
DTSTAMP:20250617T153036
DTSTART:20260120T120000
DTEND:20260120T130000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:572895a9-fada-496a-ac9f-e3dbeda8caab
DTSTAMP:20250617T153036
DTSTART:20260120T130000
DTEND:20260120T140000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:418c0d2a-9748-4f53-b5f5-4bde63977d72
DTSTAMP:20250617T153036
DTSTART:20260120T140000
DTEND:20260120T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a69bfb34-e876-4bc3-9736-2de9473ae267
DTSTAMP:20250617T153036
DTSTART:20260120T150000
DTEND:20260120T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:62065f32-45e6-4610-9c36-a96751803d3c
DTSTAMP:20250617T153036
DTSTART:20260120T160000
DTEND:20260120T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:99b4aca5-0a18-4897-8e9c-d1eeb262281b
DTSTAMP:20250617T153036
DTSTART:20260121T100000
DTEND:20260121T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0cb7fe01-de18-46d8-9a07-8cbc46c926f6
DTSTAMP:20250617T153036
DTSTART:20260121T110000
DTEND:20260121T120000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:c5078026-2eed-486b-a670-17455c044177
DTSTAMP:20250617T153036
DTSTART:20260121T120000
DTEND:20260121T130000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8e026ccd-2580-4322-8859-cf1e8d9cd33d
DTSTAMP:20250617T153036
DTSTART:20260121T130000
DTEND:20260121T140000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dee4ea08-eb88-418e-bc09-cd17ce5056b3
DTSTAMP:20250617T153036
DTSTART:20260121T140000
DTEND:20260121T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ddd5ddb2-fbab-4378-a4fd-b670daebd721
DTSTAMP:20250617T153036
DTSTART:20260121T150000
DTEND:20260121T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7eb0bf47-bdb2-41f0-8a15-545ef29a7ed6
DTSTAMP:20250617T153036
DTSTART:20260121T160000
DTEND:20260121T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8b7e34b2-3a55-416c-99e7-364fad8f543f
DTSTAMP:20250617T153036
DTSTART:20260122T100000
DTEND:20260122T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:73b9a387-b044-408c-8b44-e25448d0f542
DTSTAMP:20250617T153036
DTSTART:20260122T110000
DTEND:20260122T120000
SUMMARY:Aspirin practical drop in help on teams
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5d6f1f30-8d82-4fc3-9f5c-bb8663e16f0d
DTSTAMP:20250617T153036
DTSTART:20260122T120000
DTEND:20260122T130000
SUMMARY:Aspirin practical drop in help on teams
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2bffb847-a448-492f-96a7-d187fb3f0493
DTSTAMP:20250617T153036
DTSTART:20260122T140000
DTEND:20260122T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:82eaa2e3-c95c-43b9-b7bd-c74ad4194772
DTSTAMP:20250617T153036
DTSTART:20260122T150000
DTEND:20260122T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:61dce272-c749-4e44-ac5b-67c443954717
DTSTAMP:20250617T153036
DTSTART:20260122T160000
DTEND:20260122T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:286b1420-2da9-4df8-b84a-d75b5040f3fe
DTSTAMP:20250617T153036
DTSTART:20260123T100000
DTEND:20260123T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:eaf71fd7-ca84-4e10-83b5-aa96409d2df6
DTSTAMP:20250617T153036
DTSTART:20260123T110000
DTEND:20260123T120000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7b1fdddb-c7ab-4ff0-8418-b4c0b39c23a8
DTSTAMP:20250617T153036
DTSTART:20260123T120000
DTEND:20260123T130000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d3611f56-27c4-4c0f-8525-5d647f30db3d
DTSTAMP:20250617T153036
DTSTART:20260123T130000
DTEND:20260123T140000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:fa60c819-cd62-4a02-b46c-e459913597f5
DTSTAMP:20250617T153036
DTSTART:20260123T140000
DTEND:20260123T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b5567965-0a8b-4af6-a021-b4aa2f869315
DTSTAMP:20250617T153036
DTSTART:20260123T150000
DTEND:20260123T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8cb2e3f3-f281-4016-9e69-31882d59a242
DTSTAMP:20250617T153036
DTSTART:20260123T160000
DTEND:20260123T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:fd8cde97-8cb3-4f7d-834c-5060ca0e6364
DTSTAMP:20250617T153036
DTSTART:20260129T140000
DTEND:20260129T150000
SUMMARY:Dragons' den practice
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d3eb12e7-63f0-47cf-87d0-ac611b1e322f
DTSTAMP:20250617T153036
DTSTART:20260129T150000
DTEND:20260129T160000
SUMMARY:Dragons' den practice
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ca2d3ab1-fb18-423b-9b49-e58d3800fbb7
DTSTAMP:20250617T153036
DTSTART:20260129T160000
DTEND:20260129T170000
SUMMARY:Dragons' den practice
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:420e48c0-0eb7-4366-b141-0812c363bb65
DTSTAMP:20250617T153036
DTSTART:20260130T100000
DTEND:20260130T110000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3bb8cbde-936f-47c8-8320-eb86ff48df95
DTSTAMP:20250617T153036
DTSTART:20260130T110000
DTEND:20260130T120000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5c588a76-708c-4b21-9153-bb5388508a52
DTSTAMP:20250617T153036
DTSTART:20260130T120000
DTEND:20260130T130000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:aa11ac42-90e5-460e-bb92-9bb739742c39
DTSTAMP:20250617T153036
DTSTART:20260130T140000
DTEND:20260130T150000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:63310c4f-af32-4291-90ae-c9c1f25c17f7
DTSTAMP:20250617T153036
DTSTART:20260130T150000
DTEND:20260130T160000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e9972954-5b55-45e2-b469-5bc1b28e5caf
DTSTAMP:20250617T153036
DTSTART:20260130T160000
DTEND:20260130T170000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
END:VCALENDAR
